Solaris Pharma Corporation

About

Solaris Pharma Corporation is a specialty pharmaceutical company based in Bridgewater, New Jersey. Founded in 2014, the company focuses on identifying, developing, and marketing complex high-quality generic and specialty pharmaceutical products. With a dedicated team of approximately 34-36 employees, Solaris Pharma has achieved a revenue of $7.5 million and raised $24.12 million in funding. The company aims to improve patients' quality of life by providing affordable and effective medication options. Solaris Pharma specializes in products that face significant scientific and regulatory challenges, including complex dermatology products and various dosage forms such as topical, sterile, and tablet products. One of its notable achievements includes the FDA-approved generic version of Clindagel® (clindamycin phosphate EQ 1%). With a strong commercial infrastructure and a high approval rating, Solaris Pharma is well-positioned in the healthcare sector to meet the needs of patients and healthcare providers.